Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDApogee Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$0.86 | -$0.86 | -$0.86 |
| Q2 2025 | 1 | -$0.99 | -$0.99 | -$0.99 |
| Q3 2025 | 1 | -$0.94 | -$0.94 | -$0.94 |
| Q4 2025 | 1 | -$1.07 | -$1.07 | -$1.07 |
| Q1 2026 | 1 | -$0.98 | -$0.98 | -$0.98 |
| Q2 2026 | 1 | -$1.00 | -$1.00 | -$1.00 |
| Q3 2026 | 1 | -$1.02 | -$1.02 | -$1.02 |
| Q4 2026 | 1 | -$1.04 | -$1.04 | -$1.04 |
| Q1 2027 | 1 | -$1.07 | -$1.07 | -$1.07 |
| Q2 2027 | 1 | -$1.10 | -$1.10 | -$1.10 |
| Q3 2027 | 1 | -$1.14 | -$1.14 | -$1.14 |
| Q4 2027 | 1 | -$1.16 | -$1.16 | -$1.16 |
Apogee Therapeutics, Inc. Earnings Date And Information
Apogee Therapeutics, Inc. last posted its earnings results on Tuesday, November 12th, 2024. The company reported $-0.86 earnings per share for the quarter, topping analysts' consensus estimates of $-0.87901 by $0.01901. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Apogee Therapeutics, Inc. has generated $-3 earnings per share over the last year ($-3.36 diluted earnings per share) and currently has a price-to-earnings ratio of -15.28. Apogee Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 3rd, 2025 based on prior year's report dates.
Apogee Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2024 | Q3 2024 | -$0.88 | -$0.86 | 0.02 | $0 | $0 |
| 08/12/2024 | Q2 2024 | -$0.64 | -$0.60 | 0.04 | $0 | $0 |
| 05/13/2024 | Q1 2024 | -$0.60 | -$0.64 | -0.04 | $0 | |
| 03/05/2024 | Q4 2023 | -$0.45 | -$0.63 | -0.18 | $0 | |
| 11/13/2023 | Q3 2023 | -$0.38 | -$0.41 | -0.03 | $0 | |
| 08/28/2023 | Q2 2023 | -$1.70 | -$0.40 | 1.3 | $0 | |
| 03/30/2023 | Q1 2023 | -$0.46 | $0 | |||
| 12/30/2022 | Q4 2022 | -$2,643.83 | $0 | |||
| 09/29/2022 | Q3 2022 | -$9.46 | $0 | |||
| 06/29/2022 | Q2 2022 | -$1.45 | $0 | |||
| 03/30/2022 | Q1 2022 | -$4.20 | $0 |
Apogee Therapeutics, Inc. Earnings: FAQ's
When is Apogee Therapeutics, Inc.'s earnings date?
Apogee Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 3rd, 2025 based off last year's report dates.
Did Apogee Therapeutics, Inc. beat their earnings estimates last
quarter?
In the previous quarter, Apogee Therapeutics, Inc. (:APGE) reported $-0.86 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.87901 by $0.01901.
How can I listen to Apogee Therapeutics, Inc.'s earnings conference
call?
The conference call for Apogee Therapeutics, Inc.'s latest earnings report can be listened to online.
How can I read Apogee Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Apogee Therapeutics, Inc.'s latest earnings report can be read online.
How much profit does Apogee Therapeutics, Inc. generate each year?
Apogee Therapeutics, Inc. (:APGE) has a recorded net income of $0. Apogee Therapeutics, Inc. has generated $-3.36 earnings per share over the last four quarters.
What is Apogee Therapeutics, Inc.'s price-to-earnings ratio?
Apogee Therapeutics, Inc. (:APGE) has a price-to-earnings ratio of -15.28 and price/earnings-to-growth ratio is 0.77.